3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide

C19H32N4O5 — CID 59289107

IUPAC3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide
SMILESCC(C)[C@@H](C)NCCNC(=O)CCOCCNC(=O)CCN1C(=O)C=CC1=O
InChIInChI=1S/C19H32N4O5/c1-14(2)15(3)20-8-9-21-17(25)7-12-28-13-10-22-16(24)6-11-23-18(26)4-5-19(23)27/h4-5,14-15,20H,6-13H2,1-3H3,(H,21,25)(H,22,24)/t15-/m1/s1
InChIKeyUPMPCSKCDJBMRF-OAHLLOKOSA-N
MW396.49 g/mol
LogP-0.43
Rot. Bonds14

About 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide

3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide (PubChem CID 59289107) has the molecular formula C19H32N4O5 and a molecular weight of 396.49 g/mol. Its IUPAC name is 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide.

Molecular Properties

Compound Name3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide
PubChem CID59289107
Molecular FormulaC19H32N4O5
Molecular Weight396.49 g/mol
Exact Mass396.24
IUPAC Name3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide
SMILESCC(C)[C@@H](C)NCCNC(=O)CCOCCNC(=O)CCN1C(=O)C=CC1=O
InChIInChI=1S/C19H32N4O5/c1-14(2)15(3)20-8-9-21-17(25)7-12-28-13-10-22-16(24)6-11-23-18(26)4-5-19(23)27/h4-5,14-15,20H,6-13H2,1-3H3,(H,21,25)(H,22,24)/t15-/m1/s1
InChIKeyUPMPCSKCDJBMRF-OAHLLOKOSA-N
XLogP-0.43
TPSA116.84 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds14
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500396.49
LogP ≤ 5-0.43
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide?
The IUPAC name of 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide (CID 59289107) is 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide.
What is the SMILES notation for 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide?
The canonical SMILES for 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide is CC(C)[C@@H](C)NCCNC(=O)CCOCCNC(=O)CCN1C(=O)C=CC1=O.
What is the InChIKey of 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide?
The InChIKey is UPMPCSKCDJBMRF-OAHLLOKOSA-N. The full InChI is InChI=1S/C19H32N4O5/c1-14(2)15(3)20-8-9-21-17(25)7-12-28-13-10-22-16(24)6-11-23-18(26)4-5-19(23)27/h4-5,14-15,20H,6-13H2,1-3H3,(H,21,25)(H,22,24)/t15-/m1/s1.
What are the key properties of 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide?
3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide has a molecular weight of 396.49 g/mol, XLogP of -0.43, 14 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2,5-dioxopyrrol-1-yl)-N-[2-[3-[2-[[(2R)-3-methylbutan-2-yl]amino]ethylamino]-3-oxopropoxy]ethyl]propanamide is sourced from PubChem (CID 59289107), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).